Cappell M S, Mikhail N, Gujral N
Department of Medicine, UMDNJ-Robert Wood Johnson (formerly Rutgers) Medical School, New Brunswick, New Jersey 08903.
Dig Dis Sci. 1994 Jun;39(6):1359-64. doi: 10.1007/BF02093805.
Two patients developed unusual causes of severe gastrointestinal hemorrhage associated with anticardiolipin antibodies. One patient bled from small bowel ischemia and mesenteric thrombosis. Another patient bled massively from an ulcer of the descending duodenum which was refractory to standard antiulcer therapy. Ischemia may have contributed to the atypical ulcer presentation in this second patient, which included atypical ulcer location, ulcer refractoriness to standard peptic ulcer therapy, and severe recurrent hemorrhage. In five previously reported cases intestinal infarction associated with anticardiolipin antibodies presented, as it usually presents in patients without anticardiolipin antibodies, as an acute abdomen without acute gastrointestinal bleeding. The current study demonstrates that intestinal ischemia due to thrombosis is in the differential diagnosis of gastrointestinal bleeding in the anticardiolipin antibody syndrome.
两名患者出现了与抗心磷脂抗体相关的严重胃肠道出血的罕见病因。一名患者因小肠缺血和肠系膜血栓形成而出血。另一名患者十二指肠降部溃疡大量出血,标准抗溃疡治疗无效。缺血可能是导致第二名患者出现非典型溃疡表现的原因,包括溃疡位置不典型、对标准消化性溃疡治疗无效以及严重的反复出血。在之前报道的5例与抗心磷脂抗体相关的肠梗死病例中,其表现与通常在无抗心磷脂抗体患者中出现的情况一样,为急腹症但无急性胃肠道出血。当前研究表明,血栓形成导致的肠缺血在抗心磷脂抗体综合征所致胃肠道出血的鉴别诊断中应予以考虑。